BI
RMD icon

Binnacle Investments’s ResMed RMD Stock Holding History

Binnacle Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.12K Buy
+26
New +$7.1K ﹤0.01% 471

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Binnacle Investments's RMD Position: Q3 2025 in Review

Binnacle Investments opened a new position in ResMed (RMD) in Q3 2025: 26 shares worth $7.12K. The stake represents ﹤0.01% of the portfolio and ranks #471 among its holdings.

950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Binnacle Investments held 26 shares of ResMed worth $7.12K as of Q3 2025.
  • ResMed was a new Binnacle Investments position in Q3 2025.
  • ResMed made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #471 holding.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.